+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 73 Pages
  • August 2024
  • GlobalData
  • ID: 4286380
Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company that offers an array of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s portfolio includes products for the treatment of psychiatric, neurological, nephrological, gastroenterological, orthopedic and ophthalmologic diseases and disorders, and heart diseases. The company carries out product development, process chemistry, and manufacture of complex formulations, active pharmaceutical ingredients (APIs) and over-the-counter products. It offers drugs in various dosage forms such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids. Sun Pharma is headquartered in Mumbai, Maharashtra, India.

Sun Pharmaceutical Industries Ltd Key Recent Developments

  • Aug 01, 2024: Sun Pharmaceutical Industries Announces Results for Quarter Ended June 30, 2024
  • Jul 24, 2024: Sun Pharmaceutical Industries : Dadra Facility Receives Warning Letter from USFDA
  • Jul 16, 2024: Sun Pharma to Announce First Quarter Results on August 01, 2024
  • Jun 19, 2024: Sun Pharmaceutical : Intimation Under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Dadra Facility Receives Warning Letter From US FDA

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Sun Pharmaceutical Industries Ltd - Key Facts
  • Sun Pharmaceutical Industries Ltd - Key Employees
  • Sun Pharmaceutical Industries Ltd - Key Employee Biographies
  • Sun Pharmaceutical Industries Ltd - Major Products and Services
  • Sun Pharmaceutical Industries Ltd - History
  • Sun Pharmaceutical Industries Ltd - Company Statement
  • Sun Pharmaceutical Industries Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Sun Pharmaceutical Industries Ltd - Business Description
  • Geographical Segment: Emerging Markets
  • Performance
  • Geographical Segment: India
  • Performance
  • Geographical Segment: Rest of World
  • Performance
  • Geographical Segment: United States of America
  • Performance
  • R&D Overview
  • Sun Pharmaceutical Industries Ltd - Corporate Strategy
  • Sun Pharmaceutical Industries Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Sun Pharmaceutical Industries Ltd - Strengths
  • Sun Pharmaceutical Industries Ltd - Weaknesses
  • Sun Pharmaceutical Industries Ltd - Opportunities
  • Sun Pharmaceutical Industries Ltd - Threats
  • Sun Pharmaceutical Industries Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Sun Pharmaceutical Industries Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 01, 2024: Sun Pharmaceutical Industries Announces Results for Quarter Ended June 30, 2024
  • Jul 24, 2024: Sun Pharmaceutical Industries : Dadra Facility Receives Warning Letter from USFDA
  • Jul 16, 2024: Sun Pharma to Announce First Quarter Results on August 01, 2024
  • Jun 19, 2024: Sun Pharmaceutical : Intimation Under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Dadra Facility Receives Warning Letter From US FDA
  • Apr 03, 2024: Sun Pharma reports Q1FY24 results
  • Apr 03, 2024: Sun Pharmaceutical : Changes in Senior Management Personnel
  • Mar 29, 2024: Sun Pharmaceutical Industries Announces Board Change
  • Feb 06, 2024: Sun Pharma Announces Incorporation of a Subsidiary Company
  • Jan 31, 2024: Sun Pharma reports Q3FY24 results
  • Dec 07, 2023: Sun Pharmaceutical Industries: Intimation of Changes in Senior Management Personnel
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Sun Pharmaceutical Industries Ltd, Key Facts
  • Sun Pharmaceutical Industries Ltd, Key Employees
  • Sun Pharmaceutical Industries Ltd, Key Employee Biographies
  • Sun Pharmaceutical Industries Ltd, Major Products and Services
  • Sun Pharmaceutical Industries Ltd, History
  • Sun Pharmaceutical Industries Ltd, Subsidiaries
  • Sun Pharmaceutical Industries Ltd, Key Competitors
  • Sun Pharmaceutical Industries Ltd, Ratios based on current share price
  • Sun Pharmaceutical Industries Ltd, Annual Ratios
  • Sun Pharmaceutical Industries Ltd, Interim Ratios
  • Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Sun Pharmaceutical Industries Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sun Pharmaceutical Industries Ltd, Performance Chart (2020 - 2024)
  • Sun Pharmaceutical Industries Ltd, Ratio Charts
  • Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Viatris Inc
  • Aurobindo Pharma Ltd
  • Fresenius SE & Co KGaA
  • GlaxoSmithKline Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories Ltd
  • Sawai Pharmaceutical Co Ltd
  • Pfizer Inc
  • Zydus Lifesciences Ltd
  • Stada Arzneimittel AG
  • Novartis AG
  • Lupin Ltd
  • Teva Pharmaceutical Industries Ltd
  • Sanofi